For the twelve months ended Mar 31, 2026, Medical Properties Trust Inc. reported $1.00B of revenue and -$125.66M of net income.
MPT revenue was $252.06M in fiscal Q1 2026 (ended Mar 31, 2026), up 12.6% from a year earlier and down 6.8% from the prior quarter. For the full fiscal 2025 it was $972.02M, down 2.4% from fiscal 2024. Compound annual growth was -4.9% over 5 years and +8.2% over 10 years. It rose in 7 of the last 10 fiscal years.
MPT net income was $32.83M in fiscal Q1 2026 (ended Mar 31, 2026), compared with -$118.28M a year earlier and up 89.6% from the prior quarter. For the full fiscal 2025 it was -$277.05M, compared with -$2.41B in fiscal 2024.
MPT diluted EPS was $0.05 in fiscal Q1 2026 (ended Mar 31, 2026), compared with -$0.20 a year earlier and up 66.7% from the prior quarter. For the full fiscal 2025 it was -$0.46, compared with -$4.02 in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $972.02M | $995.55M | $871.80M | $1.54B | $1.54B | $1.25B | $854.20M | $784.52M | $704.75M | $541.14M |
| Cost of revenue | $90.31M | $74.17M | $110.07M | $167.42M | $101.44M | $30.14M | $168.21M | $84.17M | - | - |
| Gross profit | $881.72M | $921.38M | $761.73M | $1.38B | $1.44B | $1.22B | $685.99M | $700.35M | - | - |
| Selling, general and admin | $130.43M | $133.79M | $145.59M | $160.49M | $145.64M | $131.66M | $96.41M | $81.00M | $58.60M | $48.91M |
| Operating income | - | - | - | - | - | - | - | - | $485.58M | $341.64M |
| Interest expense | $510.36M | $417.82M | $411.17M | $359.04M | $367.39M | $328.73M | $237.83M | $223.27M | $176.95M | $159.60M |
| Pre-tax income | -$237.32M | -$2.36B | -$686.77M | $959.72M | $730.89M | $463.33M | $373.78M | $1.02B | $293.92M | $219.11M |
| Income tax | $38.62M | $44.10M | -$130.68M | $55.90M | $73.95M | $31.06M | -$2.62M | $927.0K | $2.68M | -$6.83M |
| Net income | -$277.05M | -$2.41B | -$556.48M | $902.60M | $656.02M | $431.45M | $374.68M | $1.02B | $289.79M | $225.05M |
| EPS, basic | -$0.46 | -$4.02 | -$0.93 | $1.50 | $1.11 | $0.81 | $0.87 | $2.77 | $0.82 | $0.86 |
| EPS, diluted | -$0.46 | -$4.02 | -$0.93 | $1.50 | $1.11 | $0.81 | $0.87 | $2.76 | $0.82 | $0.86 |
| Diluted shares | 600.9M | 600.2M | 598.5M | 598.8M | 590.1M | 530.5M | 428.3M | 366.3M | 350.4M | 261.1M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $540.86M | $332.33M | $250.02M | $235.67M | $459.23M | $549.88M | $1.46B | $820.87M | $171.47M | $83.24M |
| Total assets | $15.00B | $14.29B | $18.30B | $19.66B | $20.52B | $16.83B | $14.47B | $8.84B | $9.02B | $6.42B |
| Total debt | $9.70B | $8.85B | $10.06B | $10.27B | $11.28B | $8.87B | $7.02B | $4.04B | $4.90B | $2.91B |
| Total liabilities | $10.39B | $9.46B | $10.67B | $11.06B | $12.07B | $9.49B | $7.44B | $4.28B | $5.19B | $3.17B |
| Shareholders' equity | $4.61B | $4.83B | $7.63B | $8.59B | $8.45B | $7.34B | $7.03B | $4.56B | $3.84B | $3.25B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $230.77M | $245.48M | $505.79M | $739.01M | $811.66M | $617.64M | $494.12M | $449.09M | $362.24M | $263.84M |
| Investing cash flow | -$264.74M | $1.32B | $517.56M | $396.06M | -$3.86B | -$2.95B | -$4.88B | $564.18M | -$2.36B | -$926.54M |
| Financing cash flow | $228.08M | -$1.48B | -$1.02B | -$1.34B | $2.95B | $1.40B | $5.04B | -$345.87M | $2.07B | $552.56M |
| Share repurchases | $23.44M | - | - | $17.94M | - | - | - | - | - | - |
| Stock-based compensation | $25.75M | $32.98M | $33.25M | $49.42M | $52.11M | $47.15M | $32.19M | $16.50M | $9.95M | $7.94M |
| Depreciation and amortization | $272.82M | $453.75M | $616.13M | $345.58M | $333.78M | $275.95M | $156.57M | $141.49M | $131.98M | $97.60M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -2.4% | 14.2% | -43.5% | -0.1% | 23.6% | 46.2% | 8.9% | 11.3% | 30.2% | 22.5% |
| Net income growth, YoY | - | - | - | 37.6% | 52.1% | 15.2% | -63.1% | 250.8% | 28.8% | 61.2% |
| EPS growth, YoY | - | - | - | 35.1% | 37.0% | -6.9% | -68.5% | 236.6% | -4.7% | 36.5% |
| Gross margin | 90.7% | 92.6% | 87.4% | 89.1% | 93.4% | 97.6% | 80.3% | 89.3% | - | - |
| Operating margin | - | - | - | - | - | - | - | - | 68.9% | 63.1% |
| Net margin | -28.5% | -242.1% | -63.8% | 58.5% | 42.5% | 34.5% | 43.9% | 129.6% | 41.1% | 41.6% |
| Return on equity | -6.0% | -49.9% | -7.3% | 10.5% | 7.8% | 5.9% | 5.3% | 22.3% | 7.6% | 6.9% |
| Return on assets | -1.8% | -16.9% | -3.0% | 4.6% | 3.2% | 2.6% | 2.6% | 11.5% | 3.2% | 3.5% |
| Debt to equity | 2.11 | 1.83 | 1.32 | 1.19 | 1.34 | 1.21 | 1.00 | 0.89 | 1.28 | 0.89 |
| Line item | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $252.06M | $270.34M | $237.52M | $240.36M | $223.80M | $231.84M | $225.83M | $266.56M | $271.32M | - | $306.58M | $337.39M |
| Cost of revenue | $97.33M | $11.43M | -$22.29M | $19.76M | $81.41M | $21.13M | $7.84M | $4.32M | $40.88M | -$72.08M | $28.77M | -$28.67M |
| Gross profit | $154.73M | $258.91M | $259.81M | $220.60M | $142.39M | $210.72M | $217.99M | $262.24M | $230.43M | - | $277.81M | $366.07M |
| Selling, general and admin | $32.20M | $24.59M | $37.73M | $26.20M | $41.91M | $28.49M | $36.63M | $35.33M | $33.35M | $30.15M | $38.11M | $35.60M |
| Interest expense | $133.33M | $132.46M | $132.40M | $129.71M | $115.80M | $101.47M | $106.24M | $101.43M | $108.69M | $102.34M | $106.71M | $104.47M |
| Pre-tax income | $285.0K | $26.10M | -$66.58M | -$88.27M | -$108.58M | -$402.76M | -$791.90M | -$305.10M | -$864.43M | -$659.60M | $126.95M | -$190.69M |
| Income tax | -$32.82M | $8.51M | $10.87M | $9.80M | $9.44M | $9.56M | $9.03M | $14.56M | $10.95M | $3.98M | $10.06M | -$148.26M |
| Net income | $32.83M | $17.31M | -$77.73M | -$98.07M | -$118.28M | -$412.85M | -$801.16M | -$319.66M | -$875.38M | -$663.94M | $116.71M | -$42.43M |
| EPS, basic | $0.05 | $0.03 | -$0.13 | -$0.16 | -$0.20 | -$0.68 | -$1.34 | -$0.54 | -$1.46 | -$1.10 | $0.19 | -$0.07 |
| EPS, diluted | $0.05 | $0.03 | -$0.13 | -$0.16 | -$0.20 | -$0.68 | -$1.34 | -$0.54 | -$1.46 | -$1.10 | $0.19 | -$0.07 |
| Diluted shares | 597.7M | - | 601.1M | 600.8M | 600.6M | - | 600.2M | 600.1M | 600.3M | - | 598.6M | 598.3M |
| Line item | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $425.00M | $540.86M | $396.58M | $509.83M | $673.48M | $332.33M | $275.62M | $606.55M | $224.34M | $250.02M | $340.06M | $324.05M |
| Total assets | $14.76B | $15.00B | $14.92B | $15.15B | $14.85B | $14.29B | $15.24B | $16.19B | $17.30B | $18.30B | $19.00B | $19.20B |
| Total debt | $9.66B | $9.70B | $9.62B | $9.65B | $9.47B | $8.85B | $9.22B | $9.37B | $10.10B | $10.06B | $10.16B | $10.24B |
| Total liabilities | $10.22B | $10.39B | $10.26B | $10.32B | $10.09B | $9.46B | $9.80B | $10.00B | $10.60B | $10.67B | $10.72B | $10.89B |
| Shareholders' equity | $4.54B | $4.61B | $4.66B | $4.83B | $4.76B | $4.83B | $5.44B | $6.19B | $6.70B | $7.63B | $8.29B | $8.31B |
| Line item | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$14.26M | $160.06M | $18.57M | $51.75M | $384.0K | $76.69M | $59.20M | $35.26M | $74.34M | $135.42M | $158.19M | $76.53M |
| Investing cash flow | -$76.78M | -$7.87M | -$95.14M | -$72.32M | -$89.42M | $91.74M | $143.75M | $1.20B | -$119.26M | $170.22M | -$61.66M | $391.82M |
| Financing cash flow | -$23.22M | -$8.98M | -$34.46M | -$154.80M | $426.32M | -$99.81M | -$548.13M | -$853.52M | $22.07M | -$402.73M | -$66.66M | -$461.82M |
| Stock-based compensation | $573.0K | -$5.12M | $12.34M | $857.0K | $17.66M | $2.40M | $14.43M | $8.52M | $7.63M | $3.53M | $11.45M | $6.44M |
| Depreciation and amortization | $73.35M | $69.67M | $66.99M | $66.72M | $65.43M | $66.20M | $204.88M | $102.24M | $77.21M | $79.93M | $77.80M | $364.40M |
| Line item | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 12.6% | 16.6% | 5.2% | -9.8% | -17.5% | - | -26.3% | -21.0% | -22.5% | - | -13.0% | -15.7% |
| Net income growth, YoY | - | - | - | - | - | - | - | - | - | - | -47.4% | - |
| EPS growth, YoY | - | - | - | - | - | - | - | - | - | - | -48.6% | - |
| Gross margin | 61.4% | 95.8% | 109.4% | 91.8% | 63.6% | 90.9% | 96.5% | 98.4% | 84.9% | - | 90.6% | 108.5% |
| Net margin | 13.0% | 6.4% | -32.7% | -40.8% | -52.8% | -178.1% | -354.8% | -119.9% | -322.6% | - | 38.1% | -12.6% |
| Debt to equity | 2.13 | 2.11 | 2.06 | 2.00 | 1.99 | 1.83 | 1.69 | 1.51 | 1.51 | 1.32 | 1.23 | 1.23 |
Source: XBRL data Medical Properties Trust Inc. files with the SEC, latest filing dated May 8, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| MPT | $1.00B | +5.5% | -$125.66M | -12.6% | $1.08B |
| WELL | $13.79B | +39.2% | $1.67B | 12.1% | $179.74B |
| PLD | $8.95B | +6.7% | $3.71B | 41.5% | $120.67B |
| EQIX | $10.06B | +11.1% | $1.65B | 16.4% | $100.25B |
| AMT | $11.01B | +5.3% | $3.31B | 30.1% | $87.55B |
| SPG | $7.15B | +16.2% | $4.51B | 63.0% | $73.91B |
| DLR | $6.34B | +12.6% | $1.38B | 21.7% | $65.90B |
| PSA | $5.03B | +5.2% | $1.90B | 37.8% | $63.05B |
| O | $6.21B | +10.8% | $1.36B | 21.8% | $56.15B |